Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 13 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

13 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 8, 2020 ADMA P 4,000 $2.20 $8,800 73,174 Direct +5.78% Acquired 341.8% (price as of 2026-10-02)
Aug. 10, 2020 ADMA P 2,000 $2.88 $5,760 69,174 Direct +2.98% Acquired 237.5% (price as of 2026-10-02)
Aug. 10, 2020 ADMA P 5,000 $2.88 $14,400 67,174 Direct +8.04% Acquired 237.5% (price as of 2026-10-02)
Feb. 11, 2020 ADMA P 4,285 $3.50 $14,998 22,174 Direct +23.95% Acquired 177.7% (price as of 2026-10-02)
May 17, 2019 ADMA P 4,500 $4.00 $18,000 17,889 Direct +33.61% Acquired 143.0% (price as of 2026-10-02)
Nov. 9, 2017 ADMA P 10,000 $2.15 $21,500 13,389 Direct +295.07% Acquired 352.1% (price as of 2026-10-02)
May 3, 2016 ADMA P 770 $6.50 $5,005 3,389 Direct +29.40% Acquired 49.5% (price as of 2026-10-02)
March 16, 2015 ADMA P 1,250 $8.02 $10,025 2,565 Direct +95.06% Acquired 21.2% (price as of 2026-10-02)
May 14, 2014 ADMA P 1,315 $7.60 $9,994 1,315 Direct · Acquired 27.9% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 25, 2021 ADMA Employee Stock Option (right to buy) Common Stock (139,000) $2.35 Feb. 25, 2031 139,000 Acquired
Feb. 28, 2020 ADMA Employee Stock Option (right to buy) Common Stock (100,000) $2.92 Feb. 28, 2030 100,000 Acquired
Jan. 23, 2019 ADMA Employee Stock Option (right to buy) Common Stock (200,000) $3.22 Jan. 23, 2029 200,000 Acquired
Feb. 9, 2018 ADMA Employee Stock Option (right to buy) Common Stock (150,000) $3.71 Feb. 9, 2028 150,000 Acquired
June 6, 2017 ADMA Employee Stock Option (right to buy) Common Stock (242,546) $3.66 June 6, 2027 242,546 Acquired
Feb. 14, 2017 ADMA Employee Stock Option (right to buy) Common Stock (22,500) $5.00 Feb. 14, 2027 22,500 Acquired
Jan. 28, 2016 ADMA Options to purchase Common Stock (6,750) · Jan. 28, 2026 6,750 Acquired
Oct. 9, 2015 ADMA Options to purchase Common Stock (27,000) · Oct. 9, 2025 27,000 Acquired
Jan. 30, 2015 ADMA Options to purchase Common Stock (22,000) · Jan. 30, 2025 22,000 Acquired
June 19, 2014 ADMA Options to purchase Common Stock (29,591) · June 18, 2024 29,591 Acquired
Nov. 19, 2012 ADMA Options to purchase Common Stock (106,067) $9.60 July 18, 2022 106,067 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
July 25, 2012 ADMA No securities are beneficially owned 0 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ADMA

Chief Scientific Officer and Chief Medical Officer(7)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $216,522 · $129,250 $204,200 · · $544,118 $1,094,090
2018 $401,800 $117,325 · $312,230 · · $214,094 $1,045,449
2017 $360,500 $127,712 · $595,838 · · $86,161 $1,170,211

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.